SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward
Search This Board:
Last Post: 3/3/2015 8:47:41 AM - Followers: 293 - Board type: Free - Posts Today: 2

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 03/02/2015 06:14:57 AM
ONVO News: Securities Registration Statement (simplified Form) (s-3) 02/27/2015 05:47:59 PM
ONVO News: Current Report Filing (8-k) 02/26/2015 08:06:54 AM
ONVO News: Current Report Filing (8-k) 02/09/2015 03:15:03 PM
ONVO News: Organovo Holdings, Inc. Reports Third Quarter Results 02/09/2015 08:05:00 AM
#7214  Sticky Note Article today on CNN money shorty355 11/04/14 10:44:51 AM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#7878   I feel your pain brother. Pass them my RallyTheMarket 03/03/15 08:47:41 AM
#7877   So I own a company that will have Loco Motion 03/03/15 08:44:10 AM
#7876   The gap is at 5.50, once it's filled rumper 03/02/15 02:45:49 PM
#7875   LOL. That's a stretch. dshade 03/02/15 12:46:29 PM
#7874   I am fully ready for Keith to come RallyTheMarket 03/02/15 12:44:00 PM
#7873   Short sighted as usual. Why not watch presentation dshade 03/02/15 12:41:22 PM
#7872   You got that right. They got 150 million RallyTheMarket 03/02/15 12:37:41 PM
#7871   Yeah maybe I will see where it goes rayank 03/02/15 11:00:56 AM
#7870   Will add shortly. They will have >$150mil cash dshade 03/02/15 10:55:01 AM
#7869   My gut feeling says You might consider getting Penger 03/02/15 10:25:29 AM
#7868   Maybe good I did sell? Some dilution was rayank 03/02/15 09:21:55 AM
#7867   Appears they are going "all in" aggressively. Short dshade 02/28/15 06:40:42 AM
#7866   Well I actually sold yesterday, so as I rayank 02/27/15 04:40:57 PM
#7865   lol a response to a nothing post made RallyTheMarket 02/27/15 04:26:37 PM
#7864   Pumping would be stating a company as crazy adeezl 02/27/15 03:48:29 PM
#7863   Cool I hope for some news that will RallyTheMarket 02/27/15 10:13:13 AM
#7862   March 5th dshade 02/27/15 08:46:19 AM
#7861   March 5 ONVO Presentation... dshade 02/27/15 08:44:09 AM
#7860   Yes they try and try post SA articles dshade 02/26/15 03:37:17 PM
#7859   Desperate: feeling, showing or involving a hopeless sense RallyTheMarket 02/26/15 03:36:01 PM
#7858   Another silly SA short article. Desperate and obvious. dshade 02/26/15 03:15:23 PM
#7857   8-k. ONVO vision expanding into proprietary drug development dshade 02/26/15 08:25:26 AM
#7856   :-) rayank 02/24/15 11:07:27 PM
#7855   kidney tissue validation to hit any day now. Big_Money_Upward 02/24/15 07:42:00 PM
#7854   NEWS: Big_Money_Upward 02/24/15 07:32:08 PM
#7853   You may be right. :-) rayank 02/24/15 03:28:04 PM
#7852   I guess that's why patience is a virtue. RallyTheMarket 02/24/15 02:55:15 PM
#7851   Institutional Ownership has now Increased to 24.84%,.. a CommonCents4Dollars 02/24/15 02:30:02 PM
#7850   Precisely, to be early in this stock is RandolRocketman 02/24/15 02:29:39 PM
#7849   With the endlessly bright future this company is RallyTheMarket 02/24/15 02:04:02 PM
#7848   Yes, hard to be out of this and rayank 02/21/15 10:27:57 PM
#7847   These blog writers need to watch a recent dshade 02/21/15 10:15:11 PM
#7846   Yes I am in at $6.00, so I rayank 02/21/15 05:59:20 PM
#7845   Yeah the tech & science is very cool, wiredawg 02/21/15 05:35:39 PM
#7844   I am in this still but just posting rayank 02/21/15 05:09:05 PM
#7843   No kidding! It's been like this for a bramkers 02/20/15 02:49:53 PM
#7842   Why are the charts for this ticker not RandolRocketman 02/20/15 11:23:41 AM
#7841   I only copy and pasted that part of rayank 02/19/15 07:43:51 AM
#7840   On Mar 21 @Organovo will be exhibiting their dshade 02/19/15 07:36:27 AM
#7839   See reason. Tax purposes. dshade 02/19/15 07:26:42 AM
#7838   New insider filings for ONVO: ORGANOVO HOLDINGS, INC. rayank 02/19/15 06:44:58 AM
#7837   This company is Motorcraft, GM and Mopar combined. Ultimate01 02/17/15 07:35:32 PM
#7836   I am always honest. Go ONVO. No need dshade 02/17/15 07:14:51 PM
#7835   And to be honest there's nothing really constructive RallyTheMarket 02/17/15 03:25:22 PM
#7834   Shorts are hoping that no one wants this. RallyTheMarket 02/17/15 03:22:55 PM
#7833   Do you want this to go up or dshade 02/17/15 12:39:29 PM
#7832   Used ToGet A BuckOrTwo OutOf A Positive Article rumper 02/17/15 12:01:37 PM
#7831   MAINSTREAM MEDIA KICKING UP.... Big_Money_Upward 02/17/15 10:24:34 AM
#7830   CBCNEWS: Big_Money_Upward 02/17/15 10:21:50 AM
#7829   With 80% conversion rate ONVO is no lotto dshade 02/17/15 09:28:25 AM